Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 1
1984 1
1985 1
1986 1
1987 1
1988 1
1989 2
1991 1
1992 1
1993 1
1995 2
1999 2
2001 1
2002 1
2003 1
2007 2
2011 2
2012 1
2013 1
2014 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

25 results
Results by year
Filters applied: . Clear all
Page 1
Novel small molecule inhibitors of TLR7 and TLR9: mechanism of action and efficacy in vivo.
Lamphier M, Zheng W, Latz E, Spyvee M, Hansen H, Rose J, Genest M, Yang H, Shaffer C, Zhao Y, Shen Y, Liu C, Liu D, Mempel TR, Rowbottom C, Chow J, Twine NC, Yu M, Gusovsky F, Ishizaka ST. Lamphier M, et al. Among authors: ishizaka st. Mol Pharmacol. 2014 Mar;85(3):429-40. doi: 10.1124/mol.113.089821. Epub 2013 Dec 16. Mol Pharmacol. 2014. PMID: 24342772
Effective antibody therapy induces host-protective antitumor immunity that is augmented by TLR4 agonist treatment.
Wang S, Astsaturov IA, Bingham CA, McCarthy KM, von Mehren M, Xu W, Alpaugh RK, Tang Y, Littlefield BA, Hawkins LD, Ishizaka ST, Weiner LM. Wang S, et al. Among authors: ishizaka st. Cancer Immunol Immunother. 2012 Jan;61(1):49-61. doi: 10.1007/s00262-011-1090-7. Epub 2011 Aug 13. Cancer Immunol Immunother. 2012. PMID: 21842208 Free PMC article.
The extra domain A of fibronectin activates Toll-like receptor 4.
Okamura Y, Watari M, Jerud ES, Young DW, Ishizaka ST, Rose J, Chow JC, Strauss JF 3rd. Okamura Y, et al. Among authors: ishizaka st. J Biol Chem. 2001 Mar 30;276(13):10229-33. doi: 10.1074/jbc.M100099200. Epub 2001 Jan 9. J Biol Chem. 2001. PMID: 11150311 Free article.
25 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page